The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
Strengths
The stock, which is currently worth 2020 to 0.49 times its sales, is clearly overvalued in comparison with peers.
Weaknesses
Technically, the stock approaches a strong medium-term resistance at GBX 360.5.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
Low profitability weakens the company.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an expected P/E ratio at 944.97 and 38.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
